Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
30 participants
INTERVENTIONAL
2022-09-05
2026-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Investigating Transcranial Alternating Current Stimulation (tACS) Preconditioning Effects on Resting and Active Motor Threshold
NCT05503823
Longitudinal Study to Investigate Different Transcranial Electrical Stimulation
NCT06877312
Quantifying tACS-driven Improvement of Working Memory in Depression
NCT06110715
Long- Term Transcranial Direct Current Stimulation in Parkinson's Disease
NCT03638531
High-Definition Transcranial Direct Current Stimulation (HD-tDCS) for Sensory Deficits in Complex Traumatic Brain Injury
NCT03799458
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Frontoparietal Slow Theta Stimulation
Participants will receive multi-electrode transcranial alternating current stimulation over the prefrontal and parietal brain regions that induces frontal-to-parietal traveling wave at the frequency of 4 Hz with the intensity of up to 2 mA and duration up to 20 min.
Transcranial alternating current stimulation (tACS)
Non-invasive, multi-electrode transcranial alternating current stimulation (tACS) over frontal and parietal brain areas.
Frontoparietal Fast Theta Stimulation
Participants will receive multi-electrode transcranial alternating current stimulation over the prefrontal and parietal brain regions that induces frontal-to-parietal traveling wave at the frequency of 7 Hz with the intensity of up to 2 mA and duration up to 20 min.
Transcranial alternating current stimulation (tACS)
Non-invasive, multi-electrode transcranial alternating current stimulation (tACS) over frontal and parietal brain areas.
Parietofrontal Slow Theta Stimulation
Participants will receive multi-electrode transcranial alternating current stimulation over the prefrontal and parietal brain regions that induces parietal-to-frontal traveling wave at the frequency of 4 Hz with the intensity of up to 2 mA and duration up to 20 min.
Transcranial alternating current stimulation (tACS)
Non-invasive, multi-electrode transcranial alternating current stimulation (tACS) over frontal and parietal brain areas.
Parietofrontal Fast Theta Stimulation
Participants will receive multi-electrode transcranial alternating current stimulation over the prefrontal and parietal brain regions that induces parietal-to-frontal traveling wave at the frequency of 7 Hz with the intensity of up to 2 mA and duration up to 20 min.
Transcranial alternating current stimulation (tACS)
Non-invasive, multi-electrode transcranial alternating current stimulation (tACS) over frontal and parietal brain areas.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transcranial alternating current stimulation (tACS)
Non-invasive, multi-electrode transcranial alternating current stimulation (tACS) over frontal and parietal brain areas.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Confident level of English language.
Exclusion Criteria
2. Metal or electric implant in the head, neck, or chest area.
3. History of head injuries with loss of consciousness.
4. Any acute or chronic medical condition that requires ongoing pharmacological treatment.
5. Pregnancy or breast-feeding.
6. Alcohol or drug addiction.
18 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Brain & Behavior Research Foundation
OTHER
University of Minnesota
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ivan Alekseichuk, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Minnesota
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Minnesota
Minneapolis, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
30064
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
STUDY00002876
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.